ADMA Competitors & Alternatives
Compare ADMA Biologics Inc with similar stocks in the same industry
Biotechnology
ADMA
Main Stock$8.56
Tradestie Score
57
Market Cap
$3.59B
P/E Ratio
12.2
Revenue Growth
0.2%
Analyst Upside
+105.6%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.61
|
$2.02B | 50.4 | 53 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$15.47
|
$2.01B | - | 56 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$36.41
|
$1.97B | - | 63 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$10.56
|
$1.92B | - | 62 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$92.08
|
$1.92B | - | 52 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$75.47
|
$1.90B | 418.1 | 66 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$37.90
|
$1.84B | - | 57 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.44
|
$1.81B | - | 59 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.87
|
$1.78B | - | 56 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$20.96
|
$1.78B | - | 60 | Compare |
More ADMA Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
221 stocks in this industry